Thanks to Barcode27, Trojan09, shaken, for your ey

Thanks to Barcode27, Trojan09, shaken, for your eyewitness accounts. Very pertinent information for shareholders. I was very encouraged about Gerald's description of the market for Lympro as "Massive" as we await the numbers. The discussions regarding the patent protection for MANF should relieve anyone anxious about that, as the patents will extend 12 years once a product is commercialized. How many applications are there going to be???? MANY. The fact that Dr. Rubinfeld is coaching Gerald through the paces is very exciting and encouraging, but is no surprise, as we all assumed that already. Furthermore the fact that there is no "mad rush" to up list at the present pps is also assuring as a shareholder. The ASM has done nothing but deepen my resolve to stay the coarse, and add when I am able, which will hopefully be very soon! 2015 looks to be the year when AMBS will break onto the world stage in a BIG way!